Observations of Arp 220 using Herschel-SPIRE: An Unprecedented View of the Molecular Gas in an Extreme Star Formation Environment

We present Herschel SPIRE-FTS observations of Arp~220, a nearby ULIRG. The FTS continuously covers 190 -- 670 microns, providing a good measurement of the continuum and detection of several molecular and atomic species. We detect luminous CO (J = 4-3 to 13-12) and water ladders with comparable total luminosity; very high-J HCN absorption; OH+, H2O+, and HF in absorption; and CI and NII. Modeling of the continuum yields warm dust, with T = 66 K, and an unusually large optical depth of ~5 at 100 microns. Non-LTE modeling of the CO shows two temperature components: cold molecular gas at T ~ 50 K and warm molecular gas at T ~1350 K. The mass of the warm gas is 10% of the cold gas, but dominates the luminosity of the CO ladder. The temperature of the warm gas is in excellent agreement with H2 rotational lines. At 1350 K, H2 dominates the cooling (~20 L_sun/M_sun) in the ISM compared to CO (~0.4 L_sun/M_sun). We found that only a non-ionizing source such as the mechanical energy from supernovae and stellar winds can excite the warm gas and satisfy the energy budget of ~20 L_sun/M_sun. We detect a massive molecular outflow in Arp 220 from the analysis of strong P-Cygni line profiles observed in OH+, H2O+, and H2O. The outflow has a mass > 10^{7} M_sun and is bound to the nuclei with velocity < 250 km/s. The large column densities observed for these molecular ions strongly favor the existence of an X-ray luminous AGN (10^{44} ergs/s) in Arp 220.Comment: Accepted in ApJ on September 1, 201

UNBOUND

Featured here, are the extraordinary works of our graduating Fashion Design class. This accomplishment is truly a celebration of the tree years of passion, hard work, and dedication of our students. It\u27s our hope that the fashion industry will partake in the creative endeavors of the emerging designers from the Fashion Design program at Fanshawe College in London, Ontario.https://first.fanshawec.ca/famd_design_fashiondesign_unbound/1002/thumbnail.jp

Model-based scenarios for achieving net negative emissions in the food system

Most climate mitigation scenarios point to a combination of GHG emission reductions and CO2 removal for avoiding the most dangerous climate change impacts this century. The global food system is responsible for ~1/3 of GHG emissions and thus plays an important role in reaching emission targets. Consumers, technology innovation, industry, and agricultural practices offer various degrees of opportunity to reduce emissions and remove CO2. However, a question remains as to whether food system transformation can achieve net negative emissions (i.e., where GHG sinks exceed sources sector wide) and what the capacity of the different levers may be. We use a global food system model to explore the influence of consumer choice, climate-smart agro-industrial technologies, and food waste reductions for achieving net negative emissions for the year 2050. We analyze an array of scenarios under the conditions of full yield gap closures and caloric demands in a world with 10 billion people. Our results reveal a high-end capacity of 33 gigatonnes of net negative emissions per annum via complete food system transformation, which assumes full global deployment of behavioral-, management- and technology-based interventions. The most promising technologies for achieving net negative emissions include hydrogen-powered fertilizer production, livestock feeds, organic and inorganic soil amendments, agroforestry, and sustainable seafood harvesting practices. On the consumer side, adopting flexitarian diets cannot achieve full decarbonization of the food system but has the potential to increase the magnitude of net negative emissions when combined with technology scale-up. GHG reductions ascribed to a mixture of technology deployment and dietary shifts emerge for many different countries, with areas of high ruminant production and non-intensive agricultural systems showing the greatest per capita benefits. This analysis highlights potential for future food systems to achieve net negative emissions using multifaceted “cradle-to-grave” and “land-to-sea” emission reduction strategies that embrace emerging climate-smart agro-industrial technologies

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

When the Body Forgets to Heal

Peer Reviewe

Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma

Introduction: Single-dose inhaled corticosteroids (ICS) induce direct anti-inflammatory effects in asthma thereby improving airway hyperresponsiveness (AHR). A novel enhanced-affinity ICS, fluticasone furoate (FF), demonstrated a prolonged duration of action in vitro. The aim of this study was to evaluate the efficacy and duration of action of a single dose of FF by studying protection against AHR to adenosine 5`-monophosphate (AMP) and effects on exhaled nitric oxide (eNO). Methods: A randomized, double-blind, placebo-controlled, 6-way crossover study (FFA10026) was performed in 24 patients with allergic asthma (mean age 32.8 years, FEV1 >= 70% predicted and PC20 AMP Results: FF significantly improved PC20 AMP compared to placebo, the difference in doubling concentrations being 2.18 (95% confidence interval: 1.13-3.23), 1.54 (0.48-2.59), and 1.30 (0.26-2.34) at 2, 14 and 26 h. FP improved PC20 AMP significantly at 14 h compared to placebo, but not at the 26-hour time point, the difference in doubling concentrations being 1.72 (0.70-2.75) and 0.33 (-0.69-1.34). There was no significant effect on eNO after either FF or FP at all time points. FF was well tolerated and there were no serious adverse events. Conclusion: The new inhaled corticosteroid FF, but not FP, demonstrates prolonged protection up to 26 h against AHR to AMP in asthma patients